Table 2.
S. no | Adverse events | Immediate < 6 h postop | Early 6 h–48 h postop | Late 48 h–21 days postop |
---|---|---|---|---|
1. | Abdominal discomfort | 12 | 06 | - |
2. | Hypersentivity reaction | - | - | - |
3. | Nausea | 14 | 02 | - |
4. | Hemorrhage | - | 01* | - |
5. | Pain | - | - | - |
6. | Paralytic ileus | - | 03 | - |
7. | Burst abdomen/ wound dehiscence | - | - | 03 |
8. | Sepsis | - | - | 01# |
9. | Cardio pulmonary event | - | - | - |
10. | Thromboembolic event | - | - | - |
11. | Nephrotoxicity | - | - | - |
12. | Fatigue | - | - | 07 |
13. | Neuropathy | - | - | - |
14. | Neutropenia (ANC < 1500 cells) | - | - | - |
15. | Fever | - | 04 | - |
*Case with grade-3 splenic hilum hemorrhage, underwent re-exploration after 24 h
# Case of sepsis, reported after 28 days, died